Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease
NCT06160622 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2024-02-02
Summary
This study will assess the effect of severe kidney impairment on the pharmacokinetics (PK), safety and tolerability of Leritrelvir.
Conditions
- Kidney Impairment
Interventions
- DRUG
-
Leritrelvir
Oral
Sponsors & Collaborators
-
Guangdong Raynovent Biotech Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-26
- Primary Completion
- 2023-12-12
- Completion
- 2023-12-12
Countries
- China
Study Locations
More Related Trials
-
A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment
NCT00750620 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers
NCT00733265 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function
NCT02678000 ·Status: COMPLETED ·Phase: PHASE2
-
Single-Dose PK Study of GBT440 in Subjects With Renal Impairment
NCT03161015 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Enlicitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Participants With Moderate Renal Impairment (MK-0616-007)
NCT05070390 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants
NCT05363215 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function
NCT01309438 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment
NCT04859439 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function
NCT06039254 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects
NCT02022748 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function
NCT01372826 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
NCT01419041 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics in Subjects With Renal Impairment
NCT01504165 ·Status: COMPLETED ·Phase: PHASE1
-
Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis
NCT00704678 ·Status: COMPLETED ·Phase: PHASE2
-
RBT-1 Phase 1b Clinical Trial in Healthy Volunteers and Subjects With CKD
NCT03630029 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers
NCT01578928 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants.
NCT05282030 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function
NCT05032235 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function
NCT07322016 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine
NCT01675973 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacokinetics of Oral Letermovir in Adults With End-Stage Kidney Disease With or Without Haemodialysis
NCT07101055 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects
NCT05954169 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT06446310 ·Status: RECRUITING ·Phase: PHASE3
-
A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)
NCT06814119 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects
NCT05948059 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1